Sandip Patel, MD, is a board-certified medical oncologist who specializes in cancer immunotherapy and early phase clinical trials involving immunotherapy across all types of cancer. Dr. Patel is focused on developing personalized therapies that stimulate a patient’s immune system to attack their specific tumor. He believes in offering these promising immunotherapeutics across all tumor types.
As an associate professor in the Department of Medicine, Dr. Patel instructs medical students, residents and fellows. His research focuses on developing biomarkers for personalized immunotherapy to better determine which combination of therapies works best for each individual.
Dr. Patel completed a fellowship in medical oncology and hematology at Duke University School of Medicine, Duke Medical Center, and a residency in internal medicine at UC Los Angeles School of Medicine, UCLA Medical Center. He earned his medical degree at Baylor College of Medicine, while performing research at MD Anderson Cancer Center. He is board certified in internal medicine, medical oncology, and hematology. You can read more about Dr. Patel here.
None
For this new addition to the GRACE Lung Cancer Video Library, Dr. Sandip Patel joins GRACE to discuss current updates in non small cell lung cancer.
In this video, Dr. Patel discusses updated information on emerging molecular targets in nsclc - EGFR Exon 20.
To join the conversation, visit https://cancergrace.org/forum.
For this new addition to the GRACE Lung Cancer Video Library, Dr. Sandip Patel joins GRACE to discuss current updates in non small cell lung cancer.
In this video, Dr. Patel discusses updated information on emerging molecular targets in nsclc - KRAS.
To join the conversation, visit https://cancergrace.org/forum.
Dr. Sandip Patel, Associate Professor of Medicine at the Moores Cancer Center, UC San Diego Health, joined GRACE to offer updates to our Lung Cancer Video Library.
In this video, Dr. Patel discusses the current status of tumor mutation burden.
We thank the following organizations for their support
Dr. Sandip Patel, Associate Professor of Medicine at the Moores Cancer Center, UC San Diego Health, joined GRACE to offer updates to our Lung Cancer Video Library.
In this video, Dr. Patel discusses evolving standards for molecular testing in advanced NSCLC.
We thank the following organizations for their support
Forum Discussions
There is not a ton of info available for Cholangiocarcinoma, so seeing information come up with new developments is always exciting. In this video, Rachna Shroff MD, chief of Gastrointestinal Medical
Hi all -- share your cancer journey here and connect with others. Cancer.gov has a good general description of Cholangiocarcinoma. This rare disease has support information and programs that can be
Keep your eye out for new Head and Neck information soon!
Gallbladder Cancer is a rare disease in which malignant cells form in the tissues of the gallbladder. Bile duct cancer or cholangiocarcinoma is a rare disease in which malignant cells form in the
The happiest of Thanksgiving to everyone! Thank you for being a part of GRACE!
Comments
I agree that not all docs are good communicators! Remember they are people just like us, filling a
Our friend and past participant Melinda Bachini shared with us some information on her clinical
It is so good to hear from you, and my sentiments are the same as Janine's. You are definitely why
You may find our clinical trial page helpful, also. https://cancergrace.org/find-clinical-trials.